Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment
Pediatric Pulmonology · 2023
DOI: 10.1002/ppul.26359 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Valeria Daccò und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Cystic Fibrosis Center, Milan, Italy. Hauptthemen laut MEDLINE: Cystic Fibrosis, Burkholderia cepacia complex, Burkholderia Infections. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Cepacia syndrome (CS) is an acute, necrotizing pneumonia with a high mortality rate, occurring in patients with cystic fibrosis (CF) infected with Burkholderia cepacia complex (BCC). Due to its low incidence, data on this condition are limited.
Methods
We conducted a systematic review of the reported cases of CS by searching MEDLINE, Embase and the Cochrane Library to improve knowledge of this rare but potentially lethal condition.
Results
We included 15 eligible articles, describing 18 cases (9 females) of CS. Median age at onset was 22 years (range: 10–60 years); median time to CS after first infection by BCC was 5 years (range: 1–26 years). Burkholderia cenocepacia was the most frequently reported causative agent. All patients received intravenous antibiotic treatment (most frequently including cotrimoxazole), while inhaled antibiotics were used in five patients (27.8%). Immunosuppressant agents were the most commonly prescribed supportive treatment ( n = 7, 38.9%). Half of the patients died (9/18, 50%).
Conclusions
This study describes epidemiological, clinical characteristics, and prognosis of CS cases reported over the last 24 years. CS is a rare yet severe complication of BCC infection in patients with CF, which occurs several years after BCC colonization and has a negative outcome in 50% of the patients. Data are too scanty to identify the most effective therapeutic approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Cystic Fibrosis Center, Milan, Italy.
- Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neonatal Intensive Care Unit, Milan, Italy.
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Clinical Pathology, Microbiology Unit, Milan, Italy.
ORCID-Profile: Gianfranco Alicandro, Carla Colombo
Zitieren
APA
Daccò, V., Alicandro, G., Consales, A., Rosazza, C., Sciarrabba, C. S., Cariani, L., & Colombo, C. (2023). Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26359
Vancouver
Daccò V, Alicandro G, Consales A, Rosazza C, Sciarrabba CS, Cariani L, et al. Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26359
BibTeX
@article{Dacc2023,
author = {Daccò, Valeria and Alicandro, Gianfranco and Consales, Alessandra and Rosazza, Chiara and Sciarrabba, Calogero S and Cariani, Lisa and Colombo, Carla},
title = {Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment},
journal = {Pediatric Pulmonology},
year = {2023},
doi = {10.1002/ppul.26359}
}
EUVIMED